Press Coverage

Patient story: Cellvizio was used to speed up diagnosis and to enable faster treatment and care

19 November 2014

Ben Carlsen is 36 years old and has been living with lung cancer for the last six months. He was referred to Dr. Aki at the Lung Center at Valley View where he experienced technology that combines detection, diagnosis and staging in one procedure. A GPS-like technology was used to locate, test and detect a lesion in the lung, and Cellvizio Confocal Endomicroscopy enabled his pulmonologist to see individual cells in the farthest reaches of his lungs.

Latest News

Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026

Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026

Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying “Triple Healing”, a Cellvizio®— Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Colitis

Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying “Triple Healing”, a Cellvizio®— Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Colitis

Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation

Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation

No results found.